Skip to Content Skip to Search

Patient organisation funding

Patient organisations – non-profit organisations founded by patients, care-givers, family members and health professionals – are important stakeholders for GSK.

They engage with healthcare providers, governments, the media, and patients to promote improved treatment and services for patients. They also campaign on issues that affect patients’ and care-givers’ lives, including increasing access to quality medicines, services and information on disease. Some carry out research into the causes of and potential treatments for specific conditions.

Pan European

National European

Details of funding provided to patient organisations across Europe can be found on the relevant market website. Where no market website currently exists, and for those GSK local operating companies that supported patient organisations in 2020, the information is either published directly on this page or in a booklet available from the local office.

Markets with websites

Denmark
Finland
France
Germany
Italy
The Netherlands
Poland 
Portugal
Spain

Markets without websites

Austria
BeLux (PDF)
Bulgaria (PDF)
Croatia (PDF)
Czech Republic (PDF)
Greece
Hungary (PDF)
Ireland (PDF)
Israel (PDF)
Latvia (PDF)
Lithuania (PDF)
Norway
Romania (PDF)
Serbia (PDF)
Slovakia (PDF)
Slovenia (PDF)
Sweden
Switzerland
Ukraine (PDF)

Back to top

UK

During 2020, we provided support to the following UK patient organisations:

Alzheimers Support (PDF)
Blood Cancer UK (PDF)
British Lung Foundation (PDF)
Cancer Support UK (PDF)
Go Girls (PDF)
Headway East London (PDF)
Jo’s Cervical Cancer Trust (PDF)
Lupus UK (PDF)
Multiple Sclerosis Therapy Centre - Mid Argyll (PDF)
New Life Counselling (PDF)
Ovarian Cancer Action (PDF)
Positively UK (PDF)
Pulmonary Hypertension Association (PDF)
Sarcoma UK (PDF)
Sickle Cell Society (PDF)
Target Ovarian Cancer (PDF)
The Eve Appeal (PDF)
Trevi House (PDF) 

GSK also provides funding to support UK community healthcare charities through the GSK IMPACT Awards, in partnership with The King’s Fund.  This annual programme recognises and promotes excellence in community healthcare, providing funding and training to help strengthen the award winners’ current management plans and support their future aspirations.

Back to top

Emerging Markets and Intercontinental

During 2020 we provided funding to the following emerging markets and intercontinental patient organisations:

Markets with websites

Brazil
Canada
Russia
South Korea
Turkey

Markets without websites

Chile (PDF)
Colombia (PDF)
Hong Kong (PDF)
Mexico (PDF)
New Zealand (PDF)
Taiwan (PDF)

Back to top

Global